Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy
- 11 January 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 41 (2) , 275-279
- https://doi.org/10.1016/s0735-1097(02)02718-3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on plateletsHeart, 2001
- Upregulation of CD40 and CD40 Ligand (CD154) in Patients With Moderate HypercholesterolemiaCirculation, 2001
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older AdultsNew England Journal of Medicine, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Reduction of atherosclerosis in mice by inhibition of CD40 signallingNature, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Serum Levels of Tumor Necrosis Factor- (TNF ) and Soluble TNF Receptors in Human Immunodeficiency Virus Type 1 Infection-Correlations to Clinical, Immunologic, and Virologic ParametersThe Journal of Infectious Diseases, 1994
- CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40.The Journal of Experimental Medicine, 1993